Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Harimoto

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Synthetic Biology (Oxford, England)|September 30, 2020
Reprogramming the proteome for cell-free protein expressionTetsuhiro Harimoto
Emerging Topics in Life Sciences|February 1, 2021
Engineering bacteria for cancer therapyTetsuhiro Harimoto, Tal Danino
Nature Protocols|July 29, 2022
A rapid screening platform to coculture bacteria within tumor spheroidsTetsuhiro Harimoto, Dhruba Deb, Tal Danino
Nature Reviews. Materials|March 11, 2026
Delivering living medicines with biomaterialsTetsuhiro Harimoto, Wei-Hung Jung, David Mooney
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 16, 2015
Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID)Nathan Herrmann, Tetsuhiro Harimoto, Robert Balshaw, et al.
Clinical & Developmental Immunology|July 18, 2013
Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registriesBosco Paes, Ian Mitchell, Abby Li, et al.
Scientific Reports|December 13, 2022
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancerDhruba Deb, Yangfan Wu, Courtney Coker, et al.
Biological Psychiatry|June 29, 2013
Zinc in depression: a meta-analysisWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, et al.
Nature Reviews Bioengineering|July 4, 2024
Bacterial therapies at the interface of synthetic biology and nanomedicineJaeseung Hahn, Suwan Ding, Jongwon Im, et al.
Comprehensive Psychiatry|January 11, 2014
Predictors of readmission to a psychiatry inpatient unitJay Moss, Abby Li, James Tobin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Synthetic Biology (Oxford, England)|September 30, 2020
Reprogramming the proteome for cell-free protein expressionTetsuhiro Harimoto
Emerging Topics in Life Sciences|February 1, 2021
Engineering bacteria for cancer therapyTetsuhiro Harimoto, Tal Danino
Nature Protocols|July 29, 2022
A rapid screening platform to coculture bacteria within tumor spheroidsTetsuhiro Harimoto, Dhruba Deb, Tal Danino
Nature Reviews. Materials|March 11, 2026
Delivering living medicines with biomaterialsTetsuhiro Harimoto, Wei-Hung Jung, David Mooney
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 16, 2015
Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID)Nathan Herrmann, Tetsuhiro Harimoto, Robert Balshaw, et al.
Clinical & Developmental Immunology|July 18, 2013
Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registriesBosco Paes, Ian Mitchell, Abby Li, et al.
Scientific Reports|December 13, 2022
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancerDhruba Deb, Yangfan Wu, Courtney Coker, et al.
Biological Psychiatry|June 29, 2013
Zinc in depression: a meta-analysisWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, et al.
Nature Reviews Bioengineering|July 4, 2024
Bacterial therapies at the interface of synthetic biology and nanomedicineJaeseung Hahn, Suwan Ding, Jongwon Im, et al.
Comprehensive Psychiatry|January 11, 2014
Predictors of readmission to a psychiatry inpatient unitJay Moss, Abby Li, James Tobin, et al.
Pageof 2